Manufacturing operations at an Actavis legacy site in Iceland will cease and products will be transferred out the country from 2016, Allergan has announced.
J. Knipper and Co. claims the acquisition of InVentiv Health’s sample management and fulfillment business makes it the largest manufacturer-to-physician drug sample services firm in the US.
The new inVentiv Health Communications Europe (iHCE) base – which officially opened last month – will serve as a marketing and support service hub or ‘super agency’ for the contract services firm’s revamped offering.
Pharmaceutical intermediate sales helped Codexis in Q1 but the US biocatalysis specialist still posted a net loss for the quarter on higher R&D spending
A customer decision to halt development of an antibiotic and end a manufacturing contract early helped Patheon to an improved set results for the first quarter of fiscal 2011.
Inyx Pharma has been given a new lease on life after it was bought by another UK firm, bringing relief after it was dragged into administration when its US parent company Inyx Inc. ran aground financially.
French chemicals company Rhodia has decided to shut down a local
production site for its Rhodia Organics business, citing
competitive pressures in the market for pharmaceutical and
agrochemical intermediates.
UK pharmaceutical packaging firm Jaycare has been sold to venture
capitalists for the second time in four years, in a deal worth more
than £45 million (€67m).